<DOC>
	<DOCNO>NCT00711321</DOCNO>
	<brief_summary>The purpose study evaluate long-term tolerability -safety AFFITOPE AD02 apply AFFiRiS 002</brief_summary>
	<brief_title>Long-term Safety Tolerability AFFITOPE AD02</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Written inform consent sign dated patient caregiver Patients participate AFF002 receive least 1 vaccination AFFITOPE AD02 Availability partner/caregiver know patient able accompany patient visit Patients receive vaccination AFFITOPE AD02 History questionable compliance visit schedule , patient expect finish clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Alzheimer</keyword>
	<keyword>Morbus Alzheimer</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Alzheimer Vaccine</keyword>
	<keyword>A-beta immunotherapy</keyword>
</DOC>